Lin Jonathan B, Sheybani Arsham, Santeford Andrea, De Maria Alicia, Apte Rajendra S
Department of Ophthalmology and Visual Sciences, Washington University in St. Louis, St. Louis, MO, USA.
Department of Developmental Biology, Washington University in St. Louis, St. Louis, MO, USA.
Transl Vis Sci Technol. 2020 Sep 15;9(10):16. doi: 10.1167/tvst.9.10.16. eCollection 2020 Sep.
To determine whether increased growth differentiation factor 15 (GDF15) in aqueous humor (AH) is associated with worse visual field loss in patients with pseudoexfoliative glaucoma (PXG).
We recruited 12 patients (6 males, 6 females) with primary open-angle glaucoma (POAG) or PXG who were scheduled to undergo glaucoma surgery. AH was obtained from the initial peripheral paracentesis for the planned glaucoma surgery, and GDF15 levels were quantified with enzyme-linked immunosorbent assay by an investigator masked to clinical information. Humphrey visual field testing was performed as a part of routine care; results were obtained by reviewing the medical record.
AH GDF15 was detectable in patients with POAG and PXG. Increased AH GDF15 was significantly associated with worse mean deviation in patients with POAG ( = -0.94; 95% confidence interval [CI], -0.99 to -0.33; = 0.02) and PXG ( = -0.92; 95% CI, -0.99 to -0.41; = 0.01).
AH GDF15 is detectable in patients with PXG and POAG. Elevated AH GDF15 is strongly associated with worse mean deviation in both subgroups. These findings suggest that GDF15 may be a molecular marker of glaucoma severity that is generalizable to multiple types of glaucoma regardless of the underlying etiology.
This study provides proof of concept that GDF15, a molecular marker of retinal ganglion stress that was initially identified in rodent models, may have clinical utility as a measure of glaucoma severity not only in POAG but also in PXG.
确定房水中生长分化因子15(GDF15)水平升高是否与剥脱性青光眼(PXG)患者更严重的视野缺损相关。
我们招募了12例计划接受青光眼手术的原发性开角型青光眼(POAG)或PXG患者(6例男性,6例女性)。通过计划中的青光眼手术最初的周边前房穿刺获取房水,由对临床信息不知情的研究人员采用酶联免疫吸附测定法定量GDF15水平。作为常规护理的一部分进行Humphrey视野检测;通过查阅病历获取结果。
POAG和PXG患者的房水中均可检测到GDF15。房水中GDF15升高与POAG患者(r = -0.94;95%置信区间[CI],-0.99至-0.33;P = 0.02)和PXG患者(r = -0.92;95%CI,-0.99至-0.41;P = 0.01)更差的平均偏差显著相关。
PXG和POAG患者的房水中可检测到GDF15。房水中GDF15升高与两个亚组中更差的平均偏差密切相关。这些发现表明,GDF15可能是青光眼严重程度的分子标志物,可推广至多种类型的青光眼,而不论潜在病因如何。
本研究提供了概念验证,即最初在啮齿动物模型中鉴定出的视网膜神经节应激分子标志物GDF15,不仅在POAG中,而且在PXG中,可能具有作为青光眼严重程度指标的临床应用价值。